Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BAC Medical Nordic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   8.0% 7.6% 8.0% 3.8% 9.2% 5.1% 11.0% 11.0%   Credit score (0-100)   32 33 30 49 26 42 22 22   Credit rating   BB BB BB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   222 784 187 486 -188 390 0.0 0.0   EBITDA   48.0 676 35.0 227 -451 121 0.0 0.0   EBIT   48.0 676 35.0 227 -451 121 0.0 0.0   Pre-tax profit (PTP)   46.5 670.0 19.0 250.0 -448.0 119.4 0.0 0.0   Net earnings   34.5 516.0 13.0 193.0 -354.0 88.4 0.0 0.0   Pre-tax profit without non-rec. items   47.5 670 19.0 250 -448 119 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   280 796 809 1,002 648 737 687 687   Interest-bearing liabilities   26.0 35.0 0.0 0.0 0.0 130 0.0 0.0   Balance sheet total (assets)   402 2,465 1,476 1,448 1,282 1,559 687 687   Net Debt   -76.0 -1,846 -985 -432 -12.0 -213 -687 -687     See the entire balance sheet 1000.0 Volume  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   222 784 187 486 -188 390 0.0 0.0   Gross profit growth   -70.7% 253.2% -76.1% 159.9% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   402 2,465 1,476 1,448 1,282 1,559 687 687   Balance sheet change%   -38.9% 513.2% -40.1% -1.9% -11.5% 21.6% -56.0% 0.0%   Added value   48.0 676.0 35.0 227.0 -451.0 120.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.6% 86.2% 18.7% 46.7% 239.9% 31.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.1% 47.2% 1.8% 17.4% -32.7% 8.5% 0.0% 0.0%   ROI %   12.8% 119.1% 4.3% 28.2% -54.2% 16.0% 0.0% 0.0%   ROE %   12.0% 96.0% 1.6% 21.3% -42.9% 12.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   69.2% 32.3% 54.8% 69.2% 50.5% 47.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -158.3% -273.1% -2,814.3% -190.3% 2.7% -175.8% 0.0% 0.0%   Gearing %   9.3% 4.4% 0.0% 0.0% 0.0% 17.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.6% 19.7% 91.4% 0.0% 0.0% 2.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.8 1.2 1.5 1.6 0.8 1.0 0.0 0.0   Current Ratio   3.2 1.5 2.2 3.0 1.8 1.8 0.0 0.0   Cash and cash equivalent   102.0 1,881.0 985.0 432.0 12.0 342.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   273.5 791.0 804.0 882.0 528.0 621.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/8 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 121 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 121 0 0   EBIT / employee   0 0 0 0 0 121 0 0   Net earnings / employee   0 0 0 0 0 88 0 0